Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Consolidation

CRL & WuXi discuss Q2 results, life after collapse of deal

03-Aug-2010 - CRL and WuXi have both vowed to independently build their capabilities, to become integrated service providers, but reported mixed financial results.

CRL abandons Wuxi takeover after shareholder opposition

30-Jul-2010 - Charles River Laboratories (CRL) has abandoned plans to buy Wuxi Pharmatech after the $1.6bn (€1.2bn) takeover failed to gain sufficient shareholder support.

Guest article

Pharma consolidation and the downstream impact on CROs

29-Jul-2010 - Significant biopharm consolidation has played a key role in reshaping the drug development sector. Viq Pervaaz, senior vice president at Aon Consulting, discusses the changes and how they will impact...

Icon op income down; “pretty active” in pursuit of M&A

28-Jul-2010 - Icon reported a dip in operating income in the second quarter but an upturn in new business, and the cash to pursue M&A, make it reasonably positive about the future....

Encorium buys Progenitor for vacc biz and global reach

20-Jul-2010 - Encorium has bought Progenitor International Research, furthering efforts to fix its financial woes by focusing on vaccines, oncology and growth in emerging markets.

Jana says Wuxi deal offers inadequate returns for CRL

19-Jul-2010 - Major Charles River Laboratories (CRL) shareholder Jana Partners says Wuxi PharmaTech deal would generate inadequate returns, citing “industry” concerns about integration.

Guest article

M&A processes, pitfalls and keys to success

15-Jul-2010 - M&A can help revitalize firms but failure to properly integrate the companies can create an inefficient, demoralized business. In this article, Viq Pervaaz, senior vice president at Aon Consulting, takes...

CRL cites WuXi synergies, client support to woo investors

15-Jul-2010 - CRL has said the WuXi buy could add up to $100m (€78m) in additional annual revenue and spoken of clients’ enthusiasm for the deal as its attempts to shore up...

Sanofi looks to sell EU research sites to Covance

12-Jul-2010 - Sanofi Aventis intends to sell two of its European research facilities to US-based contract research organisation (CRO) Covance.

Aptuit to acquire GSK’s Italian R&D centre

05-Jul-2010 - Aptuit is to acquire GSK’s Italian R&D centre, take on its 500 employees and become part of the big pharma’s CRO network.

Minapharm buys CMO ProBioGen for €30.4m

17-Jun-2010 - Egypt-based Minapharm has acquired 95 per cent of CMO ProBioGen for a possible total of €30.4m ($37.6m).

Icon and Parexel partner with B-MS to support clinical dev

15-Jun-2010 - Bristol-Myers Squibb (B-MS) has inked deals with Icon and Parexel to support the large volume of clinical development work it expects to perform in coming years.

Patheon op profit up 12%

14-Jun-2010 - Patheon has posted a 12 per cent growth in operating profit in the second quarter and said there is “strong evidence” the business environment is improving.

Interactive Quiz

US industry quiz – how much do you know about H1 2010?

11-Jun-2010 - Know your Lilly from your Lonza? Then test your industry knowledge against colleagues, peers and our community of readers by participating in our exclusive map-based quiz.

CRL shareholder criticises and opposes WuXi deal

09-Jun-2010 - CRL shareholder Jana Partners has said the attempt to buy WuXi PharmaTech is the “wrong path” and it will vote against the deal.

Novella buys Prologue to strengthen oncology services

03-Jun-2010 - US-based contract research organisation (CRO) Novella Clinical has acquired Prologue Research to enhance its offering of oncology clinical trial services.

Surya raising funds to invest in production capacity

02-Jun-2010 - India-based Surya Pharmaceuticals is planning to raise Rs 500 crore ($100m) to fund construction of an active pharmaceutical ingredient (API) production plant, according to local media reports.

i3 hopes ChinaGate opens path to regulatory success

25-May-2010 - i3 has bought contract regulatory services firm ChinaGate to build in China’s rapidly expanding drug and device clinical research market.

WuXi Q1 lab biz grows, good news for potential new owner CRL

12-May-2010 - Continued strong demand for laboratory services and improved manufacturing division performance helped Wuxi PharmaTech to grow in Q1.

News in brief

ERT buys CRS adding respiratory diagnostics to offering

04-May-2010 - Cardiac monitoring and ePRO specialist ERT has added respiratory diagnostics and device manufacturing services to its offering with the acquisition of CareFusion Research Services (CRS) for $81m (€61m).

CRL to buy WuXi for $1.6bn

26-Apr-2010 - Charles River Laboratories (CRL) is to acquire WuXi PharmaTech for $1.6bn (€1.2bn), creating a global CRO capable of offering fully integrated services from molecule creation to first-in-human testing.

News in brief

Medpace buys device testing firm Symbios

26-Apr-2010 - US CRO Medpace has move into medical device trials with acquisition of Symbios Clinical in a bid to tap into what CEO August Troendle said was a growth area for...

Oracle to buy Phase Forward $685m

19-Apr-2010 - IT giant Oracle will pay $685m (€507m) for eClinical solutions firm Phase Forward, significantly expanding its presence in the billion dollar contract clinical research sector.

Clearstone expands Toronto site but is closing NJ lab

06-Apr-2010 - Clearstone is expanding safety and esoteric capacity at its laboratory in Toronto, Canada, allowing it to close its facility in New Jersey, US and consolidate North American operations.

IRL and Epichem partner to serve Australasian market

23-Mar-2010 - IRL and Epichem have entered into a strategic alliance to provide the Australasian pharma market with services from drug discovery through to cGMP production.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...